BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26852792)

  • 21. Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center.
    Park SJ; Kim S; Lee DH; Jeong YP; Bae Y; Han EM; Huh J; Suh C
    Yonsei Med J; 2008 Aug; 49(4):601-9. PubMed ID: 18729302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
    Balachandran I; Walker JW; Broman J
    Diagn Cytopathol; 2010 Mar; 38(3):213-6. PubMed ID: 19774614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
    Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
    Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic anaplastic large cell lymphoma presenting with cutaneous manifestations in a young man: a case report.
    Vande Walle N; Van den Enden E; Fostier K; De Coninck A; Nieboer K; Velkeniers B; Lacor P
    Acta Clin Belg; 2012; 67(2):127-9. PubMed ID: 22712169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
    Lombardo M; Morabito F; Merli F; Molica S; Cavanna L; Sacchi S; Broglia C; Angrilli F; Ilariucci F; Stelitano C; Luisi D; Bertè R; Luminari S; Federico M; Brugiatelli M;
    Leuk Lymphoma; 2002 Sep; 43(9):1795-801. PubMed ID: 12685834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast implant-associated anaplastic large cell lymphoma: a case report and literature review.
    Hwang MJ; Brown H; Murrin R; Momtahan N; Sterne GD
    Aesthetic Plast Surg; 2015 Jun; 39(3):391-5. PubMed ID: 25740078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
    Ziarkiewicz-Wróblewska B; Górnicka B; Gierej B; Suleiman W; Nowacka-Cieciura E; Durlik M; Bogdańska M; Wasiutyński A; Pileri SA
    Pol J Pathol; 2008; 59(1):63-9. PubMed ID: 18655373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
    Morel A; Brière J; Lamant L; Loschi M; Haioun C; Delarue R; Tournilhac O; Bachy E; Sonet A; Amorim S; Laurent C; Gaulard P; Tilly H; Sibon D
    Eur J Cancer; 2017 Sep; 83():146-153. PubMed ID: 28735072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare case of anaplastic variant of diffuse large B-cell lymphoma presenting as a lung primary.
    Kos Z; Burns BF; Gomes MM; Sekhon HS
    Int J Surg Pathol; 2014 Apr; 22(2):167-71. PubMed ID: 23775019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
    Ramos-Gallardo G; Cuenca-Pardo J; Rodríguez-Olivares E; Iribarren-Moreno R; Contreras-Bulnes L; Vallarta-Rodríguez A; Kalixto-Sanchez M; Hernández C; Ceja-Martinez R; Torres-Rivero C
    J Invest Surg; 2017 Feb; 30(1):56-65. PubMed ID: 27537783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anaplastic large cell lymphoma and keratoacanthoma].
    Tronnier M; Merz H
    Hautarzt; 2004 Feb; 55(2):182-5. PubMed ID: 14968330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report.
    Gable AD; Clark SH; Magro CM
    J Cutan Pathol; 2012 Aug; 39(8):787-90. PubMed ID: 22612158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
    Cederleuf H; Bjerregård Pedersen M; Jerkeman M; Relander T; d'Amore F; Ellin F
    Br J Haematol; 2017 Sep; 178(5):739-746. PubMed ID: 28485010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the response to treatment and the prognosis of patients with aggressive lymphomas treated with chemotherapy followed by involved-field radiotherapy: radiographic assessment.
    Sasaki S; Shikama N; Koiwai K; Kadoya M
    Jpn J Clin Oncol; 2008 Jan; 38(1):43-8. PubMed ID: 18258714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.